Search

You searched for "Supporting"

1791 results found

Training on the go

1 December 2016 | | EYE - Cataract, EYE - Refractive, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Pathology, EYE - Paediatrics, EYE - Strabismus, EYE - Vitreo-Retinal
In this guide, we aim to provide trainees with novel ideas to maximise learning in the workplace to make the most of your working hours and balance the multiple demands on your time. They say time flies; and it really...

Management of DMO and PDR in 2019

10 October 2019 | | EYE - Vitreo-Retinal, EYE - General
An evidence-based approach to the management of diabetic macular oedema (DMO) and proliferative diabetic retinopathy (PDR) in 2019 was outlined by Sobha Sivaprasad, UK, in presentations during the Diabetic Retina scientific session September 6 2019, at the 19th European Society...

¡Hola! ¿Cómo estás?

4 August 2025 | | EYE - General
In the hustle and bustle of ¡Hola! (Hello) and ¿Cómo estás? (How are you?), a group of travellers from different parts of UK went on a Mexican adventure to explore the diverse culture of Mexico, diving straight into the turquoise...

Developments in retinal pigmentation measurement and the hopes of an equitable future

4 August 2025 | | EYE - Vitreo-Retinal, EYE - Imaging
Our AI & Oculomics co-editor, Nima Ghadiri, sat down with Abraham Olvera-Barrios from Moorfields and Anand Rajesh from the University of Washington to discuss their recent international study into retinal pigmentation and its wider clinical, technological and academic applications. Can...

The work of RNIB and ECLOs

4 December 2023 | EYE - General
With more than 2,000,000 people in the UK living with some degree of sight loss and over 300,000 registered as blind or partially sighted, it is important for anyone living with sight loss to know they’re not alone. At what...

My top five: Emerging alternatives to manage and treat nAMD

3 April 2024 | | EYE - Vitreo-Retinal
Wet (exudative or neovascular) age-related macular degeneration (AMD) is characterised by choroidal neovascularisation, in which new blood vessels from the choroid invade through Bruch’s membrane. These blood vessels proliferate beneath or through the retinal pigment epithelium (RPE), causing patients to...

My Top Five: Emerging alternatives to manage and treat nAMD

3 April 2024 | | EYE - General
Wet (exudative or neovascular) age-related macular degeneration (AMD) is characterised by choroidal neovascularisation, in which new blood vessels from the choroid invade through Bruch’s membrane. These blood vessels proliferate beneath or through the retinal pigment epithelium (RPE), causing patients to...

Welcome from Guest Editor Evelyn Mensah

3 October 2022
I loved attending RCOphth Annual Congress face-to-face in Glasgow this year. How wonderful it was to see old friends and meet new after two pandemic years. At Congress I chaired the session on ‘Racism in the NHS’ with ‘three professors’...

Orbis marks 100-millionth antibiotic dose in the fight against trachoma in Ethiopia

12 May 2023 | Orbis, antibiotics, trachoma, Ethiopia
Orbis and partners mark historic 100-millionth dose of azithromycin antibiotics in the fight to eliminate blinding trachoma in Ethiopia by 2030. This milestone was achieved 20 years after Orbis began leading mass drug administrations.

Introducing: iGLEAMS-3

2 February 2024 | conferences, iGLEAMS, MiGS, Glaucoma, Surgery, Simulation, Education, Events, AHP
30 September (Colchester FirstSite) – 1 October (Colchester ICENI Centre)

Age and gender impacts effectiveness of new gene therapy treatments for eye diseases, new study finds

14 February 2025 | research, genetics, gene therapy, pathology, education, Adeno-Associated Virus, inflammation
Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found. The University of Bristol-led study, published in Molecular Therapy, reveal how age and gender affects inflammation caused by gene...

The focus group

1 June 2015 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
I love conferences. Euretina I love above all others, and when it came to London in 2014 I was determined to attend. A few weeks before the conference was scheduled to begin a well-known pharmaceutical company sent me an email...